{"id":"https://openalex.org/A5005482901","orcid":"https://orcid.org/0000-0002-7702-0160","observed_orcids":["https://orcid.org/0000-0002-7702-0160"],"display_name":"Allison N. Siclair","raw_author_names":["Allison N. Siclair"],"full_name":"Allison N. Siclair","works_count":4,"cited_by_count":20,"summary_stats":{"2yr_mean_citedness":4.0,"h_index":2,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5005482901","orcid":"https://orcid.org/0000-0002-7702-0160","observed_orcids":["https://orcid.org/0000-0002-7702-0160"]},"affiliations":[{"institution":{"id":"https://openalex.org/I126744593","ror":"https://ror.org/04rq5mt64","display_name":"University of Maryland, Baltimore","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},"years":[2026,2025,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I126744593","ror":"https://ror.org/04rq5mt64","display_name":"University of Maryland, Baltimore","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","count":4,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","count":3,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","count":2,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","count":1,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","value":8.6e-06,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","value":7.8e-06,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","value":6.6e-06,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","value":3.7e-06,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","value":3.6e-06,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","score":0.8519999980926514},{"id":"169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","score":0.7822999954223633},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.682200014591217},{"id":"112592302","wikidata":"https://www.wikidata.org/wiki/Q1207387","display_name":"Excitatory postsynaptic potential","score":0.4659700393676758},{"id":"200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","score":0.41105592250823975}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":2},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":2},{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":4},{"year":2026,"works_count":2,"oa_works_count":1,"cited_by_count":12}],"display_name_alternatives":["Allison N. Siclair"],"block_key":"a siclair","works_api_url":"https://api.openalex.org/works?filter=author.id:A5005482901","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5005482901","updated_date":"2026-11-17T13:41:00","created_date":"2023-04-06T00:00:00"}
